SCHEMBL10072406

SCHEMBL10072406

c1ccc(CCc2cccc(NCC3CC34CCN(Cc3ccccc3)CC4)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.57
NAMPT P43490 3/20 0.45
ACHE P22303 2/20 0.42
BACE1 P56817 2/20 0.42
CYP3A4 P08684 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KCNH2 Q12809 1/20 0.40
OPRL1 P41146 1/20 0.39
NPFFR1 Q9GZQ6 1/20 0.39
NPFFR2 Q9Y5X5 1/20 0.39
SIGMAR1 Q99720 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
HIF1A Q16665 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10071963 0.90 SCN9A (0.56) SCN9ANAMPTACHEBACE1CYP3A4
SCHEMBL1709213 0.82 SCN9A (0.58) SCN9ANAMPTACHEBACE1CYP3A4
SCHEMBL10071962 0.79 SCN9A (0.57) SCN9ANAMPTACHEBACE1CYP3A4
SCHEMBL18860348 0.78 NAMPT (0.48) SCN9ANAMPTKCNH2SIGMAR1
SCHEMBL1709247 0.73 SCN9A (0.64) SCN9ANAMPTCYP3A4SIGMAR1MEN1
SCHEMBL1709211 0.73 SCN9A (0.59) SCN9ANAMPTACHEBACE1SIGMAR1
SCHEMBL1709232 0.73 SCN9A (1.00) SCN9ANAMPTACHEBACE1CYP3A4
SCHEMBL1709234 0.73 SCN9A (0.60) SCN9ANAMPTACHEBACE1CYP3A4
SCHEMBL9566388 0.69 CXCR4 (0.53) SCN9ANAMPTACHEBACE1CYP3A4
SCHEMBL29424020 0.67 CHRM4 (0.73) SCN9AACHECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012047703-A2 CYCLOPROPYL-SPIRO-PIPERIDINES USEFUL AS SODIUM CHANNEL BLOCKERS SCHERING CORPORATION (US) 2012-04-12 WO disclosed